Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/chemomab-trumpets-liver-disease-win-investors-retreat
https://www.globenewswire.com/news-release/2024/06/18/2900269/0/en/Chemomab-Therapeutics-Announces-New-Publications-Reinforcing-the-Clinical-Potential-of-Its-CCL24-Neutralizing-Antibody-CM-101-in-Primary-Sclerosing-Cholangitis.html
https://www.globenewswire.com/news-release/2024/06/06/2894550/0/en/Chemomab-Therapeutics-Presents-Data-Supporting-the-Clinical-Potential-of-CM-101-as-a-Novel-Treatment-for-Primary-Sclerosing-Cholangitis-at-EASL-2024-and-a-Gordon-Research-Conferenc.html
https://www.globenewswire.com/news-release/2024/05/17/2884126/0/en/Chemomab-Therapeutics-to-Participate-in-Upcoming-Scientific-Conferences.html
https://www.globenewswire.com/news-release/2024/05/09/2878609/0/en/Chemomab-Therapeutics-Announces-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/08/2877669/0/en/Chemomab-Therapeutics-Granted-180-Day-Extension-by-Nasdaq-to-Regain-Compliance-with-Minimum-Bid-Price-Rule.html
https://www.globenewswire.com/news-release/2024/05/02/2874019/0/en/Chemomab-Therapeutics-to-Present-at-2024-Aegis-Virtual-Conference.html
https://www.globenewswire.com/news-release/2024/04/24/2868467/0/en/Chemomab-Therapeutics-to-Report-First-Quarter-2024-Financial-Results-and-Provide-a-Business-Update.html
https://www.globenewswire.com/news-release/2024/04/18/2865252/0/en/Chemomab-Reports-New-Peer-Reviewed-Publication-Reinforcing-the-Clinical-Association-of-Its-CCL24-Target-with-Disease-Severity-and-Mortality-in-Patients-with-Systemic-Sclerosis.html
https://www.prnewswire.com/news-releases/chemomab-therapeutics-announces-year-end-and-fourth-quarter-2023-financial-results-and-provides-a-corporate-update-302082436.html